FDA Inspection
Jeffrey M. Steinberg MD, Inc., A Professional Medical CorporationJeffrey M. Steinberg MD, Inc., A Professional Medical Corporation – FDA Inspection, Sep 6, 2024
Record Details
This FDA Inspection record concerns Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation, with an inspection on September 6, 2024, issued by the Los Angeles District Office, covering biologics.
- Inspection Date
- September 6, 2024
- Product Type
- Biologics
View Company Profile
ID · d169a9c8-5fed-4484-b92a-8eddeb3a254a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1248530
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 1271.65(b)(2)Prominently labeled (limited use)
- 21 CFR 1271.47(a)Testing, screening, donor eligibility procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation
5| Date | Classification | Office | Project area |
|---|---|---|---|
| May 16, 2023 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 3, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 24, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 18, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| July 1, 2009 | OAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Jeffrey M. Steinberg MD, Inc., A Professional Medical Corporation
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.